zonguldak escort bayan free porn watch porno hikaye
izmir escort bayan
Frequently Asked Questions (FAQs)
Clinical and Translational Research – Infrastructure Network (CTR-IN) Pilot Grants
  1. What is the purpose of the CTR-IN Pilot Grants Program?
  2. What type of research activity will the CTR-IN Pilot Grants Program support?
  3. Are animal or cell culture studies supported by the CTR-IN Pilot Grants Program?
  4. Who is eligible to apply for a CTR-IN Pilot Grant?
  5. Does the Pilot Grants Program accept multiple Principal Investigator applications?
  6. What are the responsibilities of a Pilot Grant recipient?
  7. What are the permitted expenses for a CTR-IN Pilot Grant?
  8. Does the Pilot Grants Program allow large equipment purchases (i.e., > $5,000)?
  9. How much should I budget for the CTR-IN Annual Scientific Meeting in my pilot grant application?
  10. What approvals are required for conducting human research?
  11. How will pilot grant applications be reviewed?
  12. How are funding award decisions made?
  13. What are the program priorities that help to guide funding decisions?
  14. What are the reporting requirements for pilot grantees?
  15. Will there be opportunities to meet with other grantees and network with potential research partners?
  16. What other resources are available through the CTR-IN?
  17. What is the CRDEB?
  18. How much time will the CTR biostatistician have toward my pilot project?
  19. Will the biostatistician help with my pilot application?
  20. What if I use a biostatistician that is not supported through the CRDEB?
  21. What is the CREMCaD?

Top
What is the purpose of the CTR-IN Pilot Grants Program?
The CTR-IN Pilot Grant Program is a Limited Competition Mentored Career Development funding opportunity. The mission of the CTR-IN is to build clinical and translational research capacity and facilitate extramural funding success among investigators with faculty appointments at the 13 universities in the Mountain West Research Consortium. The program provides research funding, and a mentored pathway of milestones leading to publication, expansion of research skills, and career development to achieve independent investigator status as reflected in the submission of an NIH R-type grant proposal (or equivalent) in clinical or translational research.Pilot funding support can be transformative in the Mountain West by helping existing programs reach national competitiveness, addressing regional health disparities, and providing opportunities for new investigators to become successful in clinical or translational research, and for established basic scientists to transition into these areas.

Top
What type of research activity will the CTR-IN Pilot Grants Program support?
Eligible clinical ortranslational research embraces a spectrum of scientific disciplines (e.g., epidemiology, statistics, pharmacology, social and behavioral sciences, nutrition, nursing, dental health, and medicine), methodologies (e.g., observational and experimental), health professions (e.g., nursing, public health, pharmacy, clinical psychology, sports physiology, physical therapy), and medical specialties and subspecialties. Any application proposing clinical translational research meeting the NIH definition will be eligible.

Clinical research includes (1) patient-oriented research; (2) epidemiologic and behavioral studies; and (3) outcomes research and health services research. Further detail of this definition can be found in the Human Subjects Research Definitions and Terms of the PHS 398 (Part III-25): click here …

Translational research (T1-T4) includes:

  • T1, Translation to Humans: Testing basic science discoveries in humans for clinical effect and/or applicability;
  • T2, Translation to Patients: Testing new interventions in human subjects under controlled environments to form the basis for clinical applications and evidence‐based guidelines
  • T3, Translation to Practice: Research on the application of new interventions or therapies in general practice; research that yields knowledge on best ways to implement new medical interventions in the clinic; and
  • T4, Translation to Population: Investigations of factors and/or interventions that influence the health of populations; ultimately results in improved health of the public.

Top
Are animal or cell culture studies supported by the CTR-IN Pilot Grants Program?
We appreciate the fact that many pre-clinical (animal and cell culture) studies provide important information that are essential before translation to human studies is possible. However, the NIH program that funds the CTR-INrequires us to follow a strict definition of translational type 1 (T1) research that excludes most pre-clinical animal and cell culture studies. This policy supports the CTR program goal of developing new clinical and translational research programs in the region, following NIH guidelines for this type of work. These guidelines also serves to complement (rather than duplicate) support provided by other INBRE and CoBRE mechanisms at IDeA institutions that emphasize support for pre-clinical programs.

Top
Who is eligible to apply for a CTR-IN Pilot Grant?
Applicants must have a faculty-level appointment at a participating CTR-IN Institution. While the Principal Investigator of a pilot project application must be a faculty member (or hold a letter of academic title) from one of the partner institutions, other collaborators will be encouraged to participate as co-investigators to foster new clinical collaborations. Early or New Stage Investigators (click here … ) are encouraged to apply. Established researcherswanting to move from basic science into translational or clinical research also are eligible to apply.Per IDeA program policy, an awardee may not concurrently receive research funding through other IDeA mechanisms (e.g., COBRE or INBRE).

Top
Does the Pilot Grants Program accept multiple Principal Investigator applications?
The CTR-IN encourages multi-disciplinary and multi-institutional collaborations, but the CTR-IN pilot grants are designed to fund a single Principal Investigator. The inclusion of co-investigators and consultants on pilot projects is strongly encouraged.

Top
What are the responsibilities of a Pilot Grant Recipient?
Pilot Grant recipients are expected to interact with the CREMCaD, work with a mentor, utilize educational and statistical resources provided by the CRDEB, provide brief quarterly reports and a final report, and attend the CTR-IN Annual Scientific Meeting.In addition, Pilot Grant recipients are expected to use the knowledge and data obtained through CTR-IN support to develop and submit “R-level”grant proposals to NIH Institutes to continue their research, and to report on those activities both during and after the period of their Pilot award.

Top
What are the permitted expenses for a CTR-IN Pilot Grant?
Permitted expenses include support for half of the salary and benefits associated with the PI’s effort, salaries for research personnel, research supplies, and participant expenses. The PI must devote a minimum of 20% effort to the pilot grant, but please see ‘Special requirements regarding PI support’ below. All expenses must be allowable under NIH guidelines. The following are not allowable: Equipment costs over $5,000, significant foreign participation, and subcontracts to institutions located in non-IDeA states. Services provided in non-IDeA states can be purchased on a fee-for-service basis.

Budgets must also include expenses to travel to, and present at, the CTR-IN Annual Scientific Meeting. Other travel expenses are permitted if necessary for conducting field work as part of the pilot project, or for domestic travel if justified for establishing a mentorship relationship, accessing experts or other resources, or presentation of peer-reviewed findings from the project at up to one national meeting per year.

Budgets may not support office supplies, phone costs, or other costs considered to be indirect expenses under NIH guidelines, unless justified as directly related to research data collection. Facilities and Administration rates (i.e., indirect costs) will be held to 10% according to the agreement endorsed by the responsible official at each of the partner institutions. Budget items not well-justified may be reduced or removed upon the recommendation of scientific reviewers, and/or the Internal Advisory Committee.

Special requirements regarding PI support: Pilot Grant PI’s must devote at least 20% effort to the proposed research, and up to 50% effort may be proposed. While the budget narrative must reference the full amount of effort required to accomplish the proposed scope of work, the budget may request CTR-IN funds for not more than half of the PI effort. The balance of PI effort is to be covered by institutional support in the form of release from teaching, direct salary support, assignment of time provided to pursue scholarly activity, or other mechanism appropriate to the institution. This support is not formal cost share and no recording/reporting requirements exist. Budgets should list the full PI effort proposed as appropriate for their appointment in calendar months, or academic and summer months. Support requested may not exceed half of that value.

Top
Does the Pilot Grants Program allow large equipment purchases (i.e., > $5,000)?
The CTR-IN is particularly focused on building Clinical and Translational Research capacity at partner institutions by focusing on researchers and the provision of support expertise and training. Large equipment purchases (i.e., > $5,000) are not allowable expenses for Pilot Grant projects.

Top
How much should I budget for the CTR-IN Annual Scientific Meeting in my pilot grant application?
The pilot grant applicant should plan on a 3-4 day meeting in Las Vegas, NV with expenses to include hotel, airfare and local travel. There will be no registration fee. Budgeting $1500 for the pilot grant PI to attend the meeting should be sufficient.

Top
What approvals are required for conducting human research?
As with any NIH-funded research, projects must adhere to all requirements regarding protection of human subjects, including approval by the grantee’s Institutional Review Board when relevant. Funds related to collection of human subjects’ data will not be released to the investigator until necessary IRB approvals are in place. Awardees must also provide documentation of human subjects training for key personnel (e.g., CITI). Other regulatory requirements such as the use of biohazard materials will be monitored per the procedures and guidelines of the investigator’s institution.

Top
How will pilot grant applications be reviewed?
Pilot grant application will be assigned to experienced grant application reviewers. In addition to the projects significance, innovation and approach, reviewers will be asked to qualitatively respond to the following questions: (1) Are plans for future extramural grant application(s) clear?; (2) If the proposed pilot project is successful, will the findings yield sufficient preliminary data to support a future NIH grant application?; and (3) Does the pilot project include, or have the potential for leading to, multi-disciplinary and/or multi-institutional collaboration? Reviewers will be asked to adhere to standard conflict of interest guidelines.

Top
How are funding award decisions made?
Following the meeting of the scientific review committee, the external peer reviews and fundingrecommendations will be forwarded to the CTR-IN Internal AdvisoryCommittee (IAC) and the External Advisory Committee (EAC) for review. The EAC will make funding recommendations to the CTR-IN Principal Investigator. The CTR-IN PI will make final decisions on the awards based on peer-review, IAC and EAC recommendations and program priorities.

Top
What are the program priorities that help to guide funding decisions?
The primary program priorities are 1) to develop new clinical and translational research programs in the region; 2) to foster the development of investigators in the region who can conduct clinical and translational research; 3) to foster collaborations that can help achieve those goals;4) support health research relevant to rural and vulnerable populations; and 5) to provide distribution of program resources across the partner institutions concordant with the guidance of scientific peer review.

Top
What are the reporting requirements for pilot grantees?
Brief quarterly progress reports and a final report will be required of all pilot grantees. Quarterly reports will include a brief summary of research progress and milestones, expenditure of project funds, unanticipated barriers or problems, meetings with mentor(s), publications and abstracts submitted or accepted, presentations made at professional meetings, grant applications submitted or accepted, and goals for the next quarter. The first quarterly report will also identify support linkages that have been established to include, at minimum, a mentor and a biostatistician.

Top
Will there be opportunities to meet with other grantees and network with potential research partners?
Pilot Grant investigators will present interim findings and progress in a poster at the CTR-IN Annual Scientific Meeting that will be attended by Network members, experts from the External Advisory Committee, and invited outside scientists.This will serve as an opportunity for pilot investigators to highlightresearch progress and pose emerging questions, receive expert feedback, and develop external collaborations.

Top
What other resources are available through the CTR-IN?
Pilot Grant recipients will have access to, and be expected to participate in, the educational and career development activities provided by the CRDEBand the CREMCaD. They will also have access to editorial assistance for abstracts and manuscripts based on their supported work, and to editorial assistance with human subjects applications.

Top
What is the CRDEB?
The Clinical Research Design, Epidemiology, and Biostatistics(CRDEB) is a Core resource within the CTR-IN. The CRDEB provides education in the fundamentals of clinical and translational research. It supports CTR-IN investigators through assistance with study design, biostatistics, and basic data management.The CRDEB has identified a biostatistician at each partner institution who is funded by the CTR-IN and available to investigators for local support. Additional resources are available to CTR-IN investigators through the CRDEB Core, located at the University of New Mexico Clinical Translational Science Center.For more information on CRDEB please click here … .

Top
How much time will the CTR-IN biostatistician provideto assist with my pilot project?
Investigators who request biostatistical support on their project are expected to meet with the CRDEB biostatistician at their institution during the planning stage of the pilot grant proposal. Up to 50 hours of free biostatistical support on funded pilot projects will be provided through the CRDEB, exclusive of time spent preparing the proposal.

Top
Can I include biostatistician whois not supported through the CRDEB on my pilot project?
No, theCTR-IN and CRDEB will only support the designated biostatistician(s) at your institution.Another biostatistician from one of the eligible institutions could be the Principal Investigator or collaborator on a pilot grant application, but this biostatistician’s effort on the pilot grant would not be financed by the CRDEB.

Top
What is the CREMCaD?
The Clinical Research Education, Mentoring, and Career Development (CREMCaD)is a Core resource within the CTR-IN that will work with each individual Pilot Grant recipient to facilitate their development towards independent clinical or translational research. Investigators will receive access to coursework developed for training in all aspects of clinical and translationalresearch. This will be provided via multiple modalities to facilitate access by investigators with diversebackgrounds and locations. For more information on CREMCaD please click here … .

 

Contact Us

To contact the CTR-IN Administrative Core by phone, you may call (702) 895-1079 between 8:30am to 5:30pm, Monday - Friday, excluding holidays. Or, you may email us at ctr-in@unlv.edu at any time.

 

Site Map

Gwen Marchand Bio

Gwen Marchand, PhD, will serve as the Director for the new upcoming Tracking & Evaluation (T&E) Core in Years 6-10 of the MW CTR-IN Program. She is currently the Director of the University of Nevada, Las Vegas Center for Research, Evaluation, and Assessment (CREA) and oversees the evaluation training and coursework of graduate students. She is also an Associate Professor in the Department of Educational Psychology and Higher Education. Dr. Marchand received her Masters and PhD degrees in Psychology from Portland State University, Portland, Oregon.

During her doctoral degree, she focused on rural and urban disparities in access to health care and youth risk behaviors in Oregon. More recently, she collaborated on a proposed project to investigate future thinking and health behaviors in minority youth and has conducted research and evaluation in diverse areas, including but not limited to team science in biomedical research fields, community health, drug court/treatment partnerships, built environments, statewide technology use, and STEM curriculum implementation. Dr. Marchand’s expertise is in assessment and evaluation methodologies that include methods for assisting with program development, formative assessment practices for program improvement, and summative assessment to demonstrate impact. Her evaluation work is grounded in a pragmatic approach that is theory-driven and emphasizes the generation of information that is useful to program stakeholders, funders, and policy-makers. As a trained systems scientist and psychologist, she has a strong quantitative tradition that has grown to include mixed-methods including expertise in measurement and assessment strategies and development, advanced statistics and the use of explanatory mixed-methods.

Robert Seville Bio

Robert “Scott” Seville, PhD, will serve as the Associate Director of the MW CTR-IN Pilot Projects Core. He is currently a Professor of Zoology and Physiology in the College of Arts and Sciences at the University of Wyoming. Currently, he serves as the Lead Concierge for MW CTR-IN Concierge Network. Previously, he served as the Associate Dean for the University of Wyoming Outreach School where he had oversight of UW facilities, staff and programs across Wyoming including managing UW Academic Regional Centers located on each Wyoming community college and the Wind River Indian Reservation. He received his Master’s and PhD degrees, and Postdoctoral training in Zoology/Physiology/Parasitology from the University of Wyoming, Laramie, in Wyoming followed by a NSF/NATO Fellowship in Parasitology.

Dr. Seville’s research has focused on the taxonomy, systematics, and parasite-host co-evolution using gastrointestinal protozoan parasites (coccidia) in wild hosts as a model system. Additionally, he brings experience in leading and managing NIH-funded activities as the Program Director/Principal Investigator, Outreach/Education Core Director, and previously Program Coordinator for the IDeA-funded Wyoming INBRE program. In these leadership roles, he has been responsible for working with the INBRE leadership team and the University of Wyoming Office of Research and Economic Development in managing ~$35M in support from NIGMS IDeA Programs with a number of research, education programs and projects focused on addressing health disparities in rural and American Indian communities in Wyoming.

Tony Ward Bio

Tony Ward, PhD, will serve as the Director for the new upcoming Community Engagement and Outreach (CEO) Core in Years 6-10 of the MW CTR-IN Program. In addition to teaching within University of Montana’s School of Public and Community Health Sciences, Dr. Ward’s research focuses on investigating the relationship between air pollution and respiratory health, working with rural and American Indian (AI) and Alaska Native (AN) populations throughout our region. Concurrently, he is the Co-PI on two NIEHS-funded R01s investigating the impact of residential wood burning on respiratory health in both children and elderly populations living in rural and tribal areas located in the southwest, northern Rocky Mountains, and rural Alaska Native communities. He is also the Co-PI on a NIH funded Science Education Partnership Award (SEPA) project that educates rural and AI/AN students in schools throughout Montana, Idaho, and Alaska about air quality/respiratory health. Moreover, Dr. Ward is the Chair at the University of Montana, School of Public and Community Health Sciences in Missoula, Montana, and the State of Montana Director of the CEO Core for the AI/AN Clinical Translational Research Project (CTRP). Dr. Ward received his Masters degree in Environmental Science and Industrial Hygiene from the University of Houston, Clear Lake in Texas, and his PhD degree in Environmental Chemistry from the University of Montana, Missoula, in Montana along with a Postdoctoral.

Dr. Ward has experience conducting Community Based Participatory Research (CBPR) in rural and underserved communities, including AI/AN communities. His experience with the AI/AN CTRP will be a valuable asset for his role as the CEO Core Director for the CTR-IN, providing synergy for both of the IDeA Programs.

Fares Qeadan Bio

Fares Qeadan, PhD, is the Associate Director for the MW CTR-IN BERD Core. Dr. Qeadan is also an Assistant Professor of Biostatistics in the Department of Internal Medicine at the University of New Mexico (UNM) HSC. He also teaches the biostatistics courses for the Biomedical Sciences Graduate Program (BSGP) and participates in team science as a biostatistician with the UNM HSC Clinical & Translational Science Center (CTSC). He holds two Master’s degrees in Mathematics and Statistics from the University of Nevada, Reno in Nevada and Michigan State University, East-Lansing in Michigan.

Dr. Qeadan has over 10 years of experience in the field of Biostatistics and Computer Science including extensive experience in statistical design and analysis in the areas of public health/epidemiology and biostatistics centers. Moreover, he brings experience from his work at the Nevada State Health Division and work on projects for the Sandia National Labs. His research interests extend to the areas of linear models (mixed effect models), generalized linear models (logistic/Poisson regression), distribution theory (boundary cases), extreme value theory (peak over threshold), time-series with regressors, Bayesian methods for hierarchical models, and Big Data including EMR such as the Cerner Health Facts database, Medicaid, and HIS General Data Mart. Dr. Qeadan has authored a diverse body of work regarding health disparities in which he has examined wide array of topics including the Hispanic Epidemiological Paradox and health outcomes in dynamic populations. His work on health disparities involved and touched other relevant areas of research including the developing of statistical methods for neurology, immunology, microenvironment data with emphasis on cytokines and chemokines. These methods are applied on data to statistically demonstrate differentials in the immune response profiles between males and females, and different race and ethnicity groups which in turn contributes to implementing better measures and promising interventions to reduce health disparities.

Cristiana Iosef Bio

Cristiana Iosef, PhD, is the Associate Director of the Professional Development Core (PDC) for the MW CTR-IN Program. In this role, she coordinates the Advance to Funding (ATF) Program and the Grant Writing Workshops (GWW). She received her PhD degree in Immunology/Microbiology from the University of Timisoara / WUSTL School of Medicine in St. Louis, Missouri. She received her Postdoctoral training in Immunology/Virology from the Ohio State University, Wooster in Ohio, and additional Postdoctoral training in Medical Biochemistry from the University of Western Ontario in Ontario, Canada. Dr. Iosef is also an Associate Professor of Pharmacology at the University of Nevada Reno.

In this role for the ATF Program, she assists research investigators in the review of their grants prior to submission to the NIH to provide constructive feedback from our many expert reviewers to increase their probability of extramural funding. Hence, the ATF Program functions very much like a “study section”. She is also in charge of coordinating the GWWs, which assist research investigators in improving their knowledge and skills in the preparation of grants to make them more competitive for extramural grant funding. Additionally, she has extensive experience in medical research and education, including studies of health disparities associated with abnormal child development and perinatal pathologies governed by growth factor(s) deficiencies such as in a state of malnutrition.

Merle Kataoka-Yahiro Bio

Merle Kataoka-Yahiro, DrPH, MS, APRN is an Associate Director of the Professional Development Core of the MW CTR-IN Program since 2013. She coordinates the Education/Training for the PDC. She is a Professor in the School of Nursing and Dental Hygiene at the University of Hawaii at Manoa. Additionally, she has served as PI for the NIH Extramural Associates Research Development (EARDA) Awards, Office of Research Development in 2013, and served as the Section Leader and Co-Leader for the Research Centers in Minority Institutions (RCMI) Multidisciplinary and Translational Research Infrastructure Expansion Hawaii Grant (RMATRIX) from 2010 – 2014. Dr. Kataoka-Yahiro earned two Master’s degrees in Parent-Child Nursing (Rush University) and Public Health (Northwestern University) and a DrPH in Public Health from the University of Illinois, School of Public Health in Chicago, Illinois.

Dr. Kataoka-Yahiro’s research area has been in health disparities research focused on chronic disease management with vulnerable populations which include women, children, older adults, and minority populations. Currently, she is examining and analyzing population data sets of Asian Pacific Islander and Native Hawaiian groups and chronic diseases, specifically in prevention of chronic kidney disease (CKD) and associated cardiovascular risk factors (diabetes, hypertension, and obesity). Dr. Kataoka-Yahiro has mentored a cadre of diverse faculty and students through developing and providing scientific research training opportunities targeting towards health disparities research in clinical translational research.

Yiliang Zhu Bio

Yiliang Zhu, PhD, is the Director of the Biostatistics, Epidemiology and Research Design (BERD) core for the MW-CTR-IN Program. He is also a Professor in the Division of Epidemiology and Biostatistics in the Department of Internal Medicine at the College of Medicine at the University of New Mexico HSC. He received his Masters and PhD degree in Statistics from Queen’s University, Kingston and University of Toronto, Toronto, Canada.

Dr. Zhu’s expertise is in data analytics. His recent research has focused on health system and policy, health outcome evaluation, and data analytic methods. In the Loess Plateau Health Project (2013-2030) in northwestern rural China, he established a multidisciplinary, international team during his Fulbright Fellowship (2012-13) during which he and his team conducted observational and interventional studies on healthcare system development, policy assessment, health promotion, as well as health disparities within the content of the local environment and rural development. Additionally, he has actively conducted research in statistics methods, focusing on spatially and temporally clustered data and applications in health risk assessment. More recently, he has studied integrative system modeling as informed by biological mechanisms to seek ways to integrate data across heterogeneous systems. He has over 20 years of collaborative experiences in health and clinical and translational research, as well as experience in leading biostatistics research support in academic settings. He is committed to integrating biostatistics support into the fabric of MW CTR-IN clinical and translational research culture.

C. William Shuttleworth Bio

C. William “Bill” Shuttleworth, PhD, is the Core Director of the Professional Development Core (PDC) for the MW CTR-IN Program. He received dual B.Sc. degrees (with honors) in Pharmacology/Biochemistry and Anatomy from Adelaide University and Flinders University of South Australia and a PhD degree in Physiology from the University of Melbourne, Victoria in Australia. He also completed his Postdoctoral training in Physiology from the University of Nevada, Reno in Nevada.

Dr. Shuttleworth has been involved in leadership roles for the MW CTR-IN Program since its inception, having initially served as the Associate Director of the Pilot Projects Program In 2016, Dr. Shuttleworth transitioned to a leadership role for PDC [formally termed Clinical Research Education, Mentoring and Career Development (CREMCaD) in the initial funding phase]. In addition, Dr. Shuttleworth serves as the Associate Director of the University of New Mexico (UNM) Health Science Center’s (HSC) Clinical and Translational Research Center (CTSC), and has worked with a large number of UNM clinical and translational investigators to help develop new projects, programs and their careers in clinical and translational research. Moreover, he currently directs the CTSC’s Research Expertise and Methods, which includes training and career development activities that further supplements his leadership role of the CTR-IN PDC.

Dr. Shuttleworth’s research has a strong clinical and translational focus. He is the Principal Investigator of the Center for Brain Recovery and Repair, which is funded through a COBRE mechanism by the National Institute of General Medical Sciences (NIGMS). His research is developing clinical interventions for underserved patients in New Mexico who have experienced brain injuries.

Eric Prossnitz Bio

Eric Prossnitz, PhD, is the Associate Director of the Professional Development Core for the MW CTR-IN Program. As the Associate Director for the PDC, Dr. Prossnitz’s focus is on the Mentorship Program. Dr. Prossnitz is also currently the Co-Director of the Translational Cancer Biology and Signaling Program at the UNM HSC Comprehensive Cancer Center, the Team Science lead within the UNM HSC Clinical and Translational Science Center (CTSA), the UNM HSC institutional PI of the NM-INBRE, and the Associate Director for the UNM COBRE in Autophagy, Inflammation and Metabolism. Dr. Prossnitz received his B.Sc. degree (with honors) from the University of Victoria in Canada and a PhD in Biochemistry from the University of California, Berkeley in California. He received his postdoctoral in Immunology from Scripps Clinic and Research Foundation.
Additionally, Dr. Prossnitz developed a Biodesign program at UNM HSC that brings together faculty from the School of Engineering and the Health Sciences Center to innovate clinical technologies. He has mentored large numbers of research investigators to develop new projects and programs that has facilitated their careers in clinical and translational research. His mentoring experience over the last 20 years provides a strong basis for his leadership for the Mentorship Program within the CTR-IN PDC.

Curtis Noonan Bio

Curtis Noonan, MA, PhD, is the Director of the MW CTR-IN Pilot Projects Program. He has served in this role for the past five years and will continue to serve in this role for the next grant cycle. The Pilot Projects Program has successfully administered the single institution, single investigator and the multi-site pilot grants since the inception of the MW CTR-IN Program.

Dr. Noonan received his MA degree in International Health and Development from George Washington University and his PhD in Environmental Health, Epidemiology from Colorado State University. He is currently a Professor of Epidemiology in the College of Health Professions and Biomedical Sciences at the University of Montana. He has led NIH funded multi-site randomized trials focused on improving health outcomes and reducing exposures among vulnerable populations exposed to elevated levels of particulate matter from burning of biomass fuels for residential heating. Dr. Noon is a member of the Infectious, Reproductive, Asthma and Pulmonary Conditions (IRAP) Study Section.

Carl Reiber Bio

Carl Reiber, PhD, has served as the MW CTR-IN Program Deputy Director since 2013. He is also the Senior Vice Provost and a Professor in the School of Life Sciences at the University of Nevada, Las Vegas in the College of Sciences. Additionally, he has been the Program Coordinator of the NV INBRE since 2008, and the Steering Committee Lead since 2017. Previously, he was the cluster leader in two statewide NSF EPSCoR grants ($6M) and functioned as the coordinator for an NIH Bridges grant. He also served as an ad hoc and permanent member of several NSF review panels including mentoring numerous undergraduate and graduate students (MS and PhD). Dr. Reiber received his Masters degree in Cell Biology from George Mason University, Fairfax in Virginia and PhD degree in Zoology-Physiology from the University of Massachusetts in Amherst Massachusetts followed by Postdoctoral training from the University of Florida, Gainesville, Florida.

Richard Larson Bio

Richard Larson, MD, PhD, serves as the CTSC Liaison for the MW CTR-IN Program. He is the Executive Vice Chancellor for Research of Health Sciences at the University of New Mexico Health Sciences Center as well as a tenured Professor at the University of New Mexico. In addition, he is also the PI of the UNM Clinical and Translational Science Center. He also served on the Board of Directors for the National Center for Genome Research. In 2001, he co-founded Cancer Services of New Mexico, a non-profit organization which serves, free of charge, over 2000 New Mexicans suffering from cancer each year. Moreover, he is the President of the Cancer Services of New Mexico Foundation. In addition, Moreover, he also serves as the Chair of the Mountain West Research Consortium, which was critical in laying down the ground work for the eventual development of the MW CTR-IN Program. Dr. Larson received his MD and PhD degrees from Harvard University and performed his residency training at Washington University in St. Louis and fellowship training at Vanderbilt University in Pathology.

Parvesh Kumar Bio

Parvesh Kumar, MD, is the Principal Investigator (PI) of the MW CTR-IN Program. In addition, he also, serves as the Vice Dean of Research for the UNLV School of Medicine. Dr. Kumar received his B.Sc. degree (with honors) in Chemical Engineering from the University of Kansas in 1981 and his M.D. degree from the University of Kansas School of Medicine in 1986. He completed his residency training in Radiation Oncology at Thomas Jefferson University Hospital in 1990, while also serving as Chief Resident and Fellow of the American Cancer Society during his senior year.

Dr. Kumar is an experienced clinical and translational researcher who has led several multi-institutional, multi-disciplinary national oncology clinical trials sponsored by the NCI [i.e., Cancer & Leukemia Group B (CALGB) Protocols 8935 and 9134 in Non-Small Cell Lung Cancer and CALGB Protocol 9493 in Prostate Cancer, and Radiation Therapy Oncology Group Protocol Protocol 9615 in Head & Neck Cancer]. In addition, he has also conducted several other federal (i.e., Department of Defense) and pharma (i.e., Aventis Oncology) funded investigator initiated clinical trials. Moreover, his leadership experiences include building and managing research programs as Chair of the Departments of Radiation Oncology at 4 major medical schools and at several NCI-designated Cancer Centers. In his several research leadership roles, he has developed significant experience in health disparity research. For example, as Associate Director of Clinical Research for the University of Kansas Cancer Center, ensuring appropriate enrollment of under represented patient populations to therapeutic clinical trials was a critical requirement for the NCI and an important objective of his leadership role.

Xiaomeng (Mona) Xu

Dr. Xu is a 2015 MW CTR-IN Pilot Grant Awardee recipient. Her project was entitled, “Understanding the Role of Self-Expansion in Physical Activity”. Her research focuses on cardiovascular behavioral health including weight control, smoking and physical activity; close relationships, especially romantic; and magnetic resonance imaging (MRI) neuroimaging. Dr. Xu is also interested in these research areas in the context of individual differences such as trait self-control, and development over time, such as aging or as a romantic relationship progresses.

Dr. Xu received a Bachelor of Arts Degree in psychology from New York University, and Master of Arts Degree in psychology from Stony Brook University, and a Ph.D. in social health psychology from Stony Brook University. She completed a postdoctoral research fellowship sponsored by the National Institutes of Health at The Warren Alpert Medical School of Brown University and The Miriam Hospital.

Dr. Xu is an Assistant Professor of Experimental Psychology at Idaho State University and was honored as a 2015 Rising Star from the Association for Psychological Science. As a result of her advanced work in the field, the Association for Psychological Science has recognized Dr. Xu as an outstanding psychological scientist. As facilitated by the Individualized Development Plan (IDP) which is a critical component of the CTR-IN PG award, Dr. Xu had a successful mentorship experience with her mentor, Claudio Nigg, PhD, from the University of Hawaii. The pilot grant’s IDP provides mentorship for career development. As a result of the mentoring facilitated by the IDP, Dr. Xu has collaborated with Dr. Nigg on various projects, which have led to a manuscript publication, poster presentations, future collaborations, etc. Moreover, based on her academic productivity which has been significantly facilitated by the MW CTR-IN PG award, she will be applying for tenure at Idaho State University.

Susan Tavernier

Education: BSN from Whitworth University in Spokane in Washington; MSN from Loyola University of Chicago; PhD in Nursing from the University of Utah; Postdoctoral fellowship from the College of Nursing at the University of Utah.

MW CTR-IN helped to provide education in grant management, post-award processes, timeline projections, and meaningful tools for grant tracking.

Dr. Tavernier was a Year 4 MW CTR-IN Pilot Grant Awardee in 2016. Her project was entitled, “The Patient Voice in Healthcare”. The MW CTR-IN pilot grant was also instrumental in helping her with the nuances of grant management including hiring personnel, budgets, quarterly and annual reports. As a nurse scientist, her research area focuses on cancer patients. She has gained expertise with large qualitative data sets and has conducted research in the clinical setting. Dr. Tavernier is currently an Assistant Professor at Idaho State University in the School of Nursing and was a recipient of a Presidential Scholarship for new health service researchers from Academy Health.
Additionally, she has authored a chapter on Symptom Distress in the textbook Cancer Symptom Management 4th Edition, and has served as a review panel member for the Oncology Nursing Foundation for research and awards. She is also an active member of the Oncology Nursing Society.

Blakely Brown

Education: PhD in Nutritional Biochemistry from the University of Minnesota; RD from the University of Minnesota

MW CTR-IN helped to expand collaborations for a nutrition and physical activity study with a direct impact on the health of community children.

Dr. Blakely Brown was a MW CTR-IN Pilot Grant (PG) Awardee and Visiting Scholar in 2014. Her project was entitled, “Developing and Pilot Testing Parent Education Activities within a Childhood Obesity Prevention After-School Program”. Dr. Brown built upon this PG research funding from the MW CTR-IN Program and secured 3 additional extramural grants also in the areas of childhood obesity totaling $278,167 in extramural grant funding as follows: (1) Partnerships to Prevent Childhood Obesity on the Flathead Indian Reservation; (2) Generations Health Project: An After-School and Home Based Childhood Obesity Prevention Program; (3) and USDA Strengthening Grant: Growing Strong Generations. These research studies have allowed Dr. Brown to successfully expand her research collaborations with rural and Native American communities that have resulted in longitudinal outcomes reporting risk factors for diabetes in native and non-native children, assessments of environmental and behavioral factors associated with risk for childhood obesity and diabetes in youth in rural communities.
Dr. Brown’s research, teaching and service focus on nutrition and chronic disease prevention, maternal-child health, childhood obesity and diabetes prevention, community-based participatory research methods, Native American health and diversity-related activities.

kızılay escort
auto request
izmir escort escort antalya bodrum escort izmir escort bursa escort izmir escort